Hormone Replacement Therapy
Hormone Replacement Therapy (HRT), also known as menopausal hormone therapy (MHT) or postmenopausal hormone therapy (PHT), is a form of endocrine therapy that involves the administration of synthetic hormones to replace those that the body no longer produces after menopause. HRT is primarily used to treat symptoms associated with menopause, such as hot flashes, vaginal dryness, and bone loss.
Indications[edit | edit source]
HRT is indicated for the relief of menopausal symptoms, which can significantly impair quality of life. These symptoms include, but are not limited to, hot flashes, night sweats, mood swings, and vaginal atrophy. HRT is also indicated for the prevention of osteoporosis in postmenopausal women at high risk of fractures.
Types of Hormone Replacement Therapy[edit | edit source]
HRT can be administered using various formulations:
- Estrogen Therapy: This is the most common type of HRT and is prescribed for women who have had a hysterectomy, as they do not need progesterone.
- Combined HRT: This involves a combination of estrogen and progesterone, prescribed for women who still have their uterus, to protect against endometrial cancer which can be a risk with estrogen-only therapy.
- Bioidentical Hormone Replacement Therapy (BHRT): This uses hormones that are chemically identical to those the human body produces. However, claims about the safety and effectiveness of BHRT over traditional HRT remain controversial.
Administration Methods[edit | edit source]
Hormone replacement therapy can be administered through various routes:
- Oral tablets
- Transdermal patches
- Topical gels
- Vaginal creams, rings, or tablets
Risks and Benefits[edit | edit source]
- Benefits
- Alleviation of menopausal symptoms
- Prevention of bone loss and reduction in fracture risk in postmenopausal women
- Possible reduction in risk of colorectal cancer
- Risks
- Increased risk of breast cancer, particularly with combined HRT
- Risk of cardiovascular disease, including heart attacks and stroke
- Increased risk of blood clots
Controversies and Research[edit | edit source]
The use of HRT has been controversial, particularly following the publication of the Women's Health Initiative (WHI) study in 2002, which raised concerns about the risks associated with its use. Subsequent research has focused on understanding the risks and benefits more clearly and identifying which women might benefit most from HRT, with considerations of timing and duration of therapy.
Conclusion[edit | edit source]
HRT remains a critical area of research and medical practice, balancing benefits against potential risks. It is essential for healthcare providers to tailor HRT recommendations based on individual patient risk profiles and preferences.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD, Dr.T